Abstract
In photopharmacology, photoswitchable compounds including azobenzene or other diarylazo moieties exhibit bioactivity against a target protein typically in the slender E-configuration, whereas the rather bulky Z-configuration usually is pharmacologically less potent. Herein we report the design, synthesis and photochemical/inhibitory characterization of new photoswitchable kinase inhibitors targeting p38a MAPK and CK15. A well characterized inhibitor scaffold was used to attach arylazo- and diazocine moieties. When the isolated isomers, or the photostationary state (PSS) of isomers, were tested in commonly used in vitro kinase assays, however, only small differences in activity were observed. X-ray analyses of ligand-bound p38α MAPK and CK15 complexes revealed dynamic conformational adaptations of the protein with respect to both isomers. More importantly, irreversible reduction of the azo group to the corresponding hydrazine was observed. Independent experiments revealed that reducing agents such as DTT (dithiothreitol) and GSH (glutathione) that are typically used for protein stabilization in biological assays were responsible. Two further sources of error are the concentration dependence of the E-Z-switching efficiency and artefacts due to incomplete exclusion of light during testing. Our findings may also apply to a number of previously investigated azobenzene-based photoswitchable inhibitors.
Similar content being viewed by others
References
V. Balzani, A. Credi, F. M. Raymo and J. F. Stoddart, Angew. Chem., Int. Ed., 2000, 39, 3348–3391.
W. Browne and B. L. Feringa, Nat. Nanotechnol., 2006, 1, 25–35.
S. Kassem, T. van Leeuwen, A. S. Lubbe, M. R. Wilson, B. L. Feringa and D. A. Leigh, Chem. Soc. Rev., 2017, 46, 2592–2621.
K. Matsuda and M. Irie, J. Photochem. Photobiol., C, 2004, 5, 169–182.
T.-T.-T. Nguyen, D. Türp, M. Wagner and K. Müllen, Angew. Chem., Int. Ed., 2013, 52, 669–673.
G. Mayer and A. Heckel, Angew. Chem., Int. Ed., 2006, 45, 4900–4921.
A. A. Beharry and G. A. Woolley, Chem. Soc. Rev., 2011, 40, 4422–4437.
M. M. Lerch, M. J. Hansen, G. M. van Dam, W. Szymanski and B. L. Feringa, Angew. Chem., Int. Ed., 2016, 55, 10978.
K. Hüll, J. Morstein and D. Trauner, Chem. Rev., 2018, 118, 10710–10747.
W. Szymanski, M. E. Ourailidou, W. A. Velema, F. J. Dekker and B. L. Feringa, Chem. - Eur.J., 2015, 21, 16517–16524.
D. Vomasta, C. Högner, N. R. Branda and B. König, Angew. Chem., Int. Ed., 2008, 47, 7644–7647.
R. Ferreira, J. R. Nilsson, C. Solano, J. Andrésson and M. Grotli, Sci. Rep., 2015, 5, 1–8.
J. Kuil, L. T. M. van Wandelen, N. J. de Mol and R. M. J. Liskamp, Bioorg. Med. Chem., 2008, 16, 1393–1399.
A. D. Abell, M. A. Jones, A. T. Neffe, S. G. Aitken, T. P. Cain, R. J. Payne, S. B. McNabb, J. M. Coxon, B. G. Stuart, D. Pearson, H. Y.-Y. Lee and J. D. Morton, J. Med. Chem., 2007, 50, 2916–2920.
C. Falencyk, M. Schiedel, B. Karaman, T. Rumpf, N. Kuzmanovic, M. Grotli, W. Sippl, M. Jung and B. König, Chem. Sci., 2014, 5, 4794.
M. J. Hansen, W. A. Velema, G. de Bruin, H. S. Overkleeft, W. Szymanski and B. L. Feringa, ChemBioChem, 2014, 15, 2053–2057.
C. E. Weston, A. Krämer, F. Colin, Ö. Yildiz, M. G. J. Baud, F. -J. Meyer-Almes and M. J. Fuchter, ACS Infect. Dis., 2017, 3, 152–161.
D. Wutz, D. Gluhacevic, A. Chakrabarti, K. Schmidtkunz, D. Robaa, F. Erdmann, C. Romier, W. Sippl, M. Jung and B. König, Org. Biomol. Chem., 2017, 15, 4882–4896.
N. A. Smith, L.-M. Altmann, N. Wössner, E. Bauer, M. Jung and B. König, J. Org. Chem., 2018, 83, 7919–7927.
D. Wilson, J. Li and N. Branda, ChemMedChem, 2017, 12, 284–287.
C. Schwab, A. J. DeMaggio, N. Ghoshal, L. I. Binder, J. Kuret and P. L. McGeer, Neurobiol. Aging, 2000, 21, 503–510.
G. Manning, D. B. Whyte, R. Martinez, T. Hunter and S. Sudarsanam, Science, 2002, 298, 1912–1934.
J. Zhang, P. L. Yang and N. S. Gray, Nature, 2009, 9, 28–39.
A. C. Dar and K. M. Shokat, Annu. Rev. Biochem., 2011, 80, 769–795.
S. Gross, R. Rahal, N. Stransky, C. Lengauer and K. P. Hoeflich, J. Clin. Invest., 2015, 125, 1780–1789.
M. Huang, A. Shen, J. Ding and M. Geng, Trends Pharmacol. Sci., 2014, 35, 41–50.
C. Sun and R. Bernards, Trends Biochem. Sci., 2014, 39, 465–474.
S. Klaeger, S. Heinzlmeir, M. Willhelm, {etet al.}, Science, 2017, 358, 1–16.
J. Halekotte, L. Witt, C. Ianes, M. Krüger, M. Bührmann, D. Rauh, C. Pichlo, E. Brunstein, A. Luxenburger, U. Baumann, U. Knippschild, J. Bischof and C. Peifer, molecules, 2017, 22, 522.
C. E. Weston, R. D. Richardson, P. R. Haycock, A. J. P. White and M. J. Fuchter, J. Am. Chem. Soc., 2014, 136, 11878–11881.
J. Otsuki, K. Suwa, K. K. Sarker and J. Sinha, J. Phys. Chem. A, 2007, 111, 1403–1409.
R. Siewertsen, H. Neumann, B. Buchheim-Stehn, R. Herges, C. Näther, F. Renth and F. Temps, J. Am. Chem. Soc., 2009, 131, 15594–15595.
S. Laufer and P. Koch, Org. Biomol. Chem., 2008, 6, 437–439.
S. Laufer and A. J. Liedtke, Tetrahedron Lett., 2006, 47, 7199–7203.
H. Beyer and G. Henseke, Chem. Ber., 1950, 88, 1233–1236.
B. Sahlmann, PhD Thesis, Christian-Albrechts-University Kiel, 2013.
M. Dommaschk, M. Peters, F. Gutzeit, C. Schütt, C. Näther, F. D. Sönnichsen, S. Tiwari, C. Riedel, S. Boretius and R. Herges, J. Am. Chem. Soc., 2015, 137, 7552–7555.
M. J. Hansen, M. M. Lerch, W. Szymanski and B. L. Feringa, Angew. Chem., Int. Ed., 2016, 55, 13514–13518.
T. Wendler, C. Schütt, C. Näther and R. Herges, J. Org. Chem., 2012, 77, 3284–3287.
J. Roger and H. Doucet, Tetrahedron, 2009, 65, 9772–9781.
M. Hammerich, C. Schütt, C. Stähler, P. Lentes, F. Röhricht, R. Höppner and R. Herges, J. Am. Chem. Soc., 2016, 138, 13111–13114.
H. Kim, I. Yang, R. S. Patil, S. Kang, J. Lee, H. Choi, M.-S. Kim, S.-J. Nam and H. Kang, J. Nat. Prod., 2014, 77, 2716–2719.
D. K. Joshi, M. J. Mitchell, D. Bruce, A. J. Lough and H. Yan, Tetrahedron, 2012, 68, 8670–8676.
J. Calbo, C. E. Weston, A. J. P. White, H. S. Rzepa, J. Contreras-García and M. J. Fuchter, J. Am. Chem. Soc., 2017, 139, 1261–1274.
S. Devi, M. Saraswat, S. Grewal and S. Venkataramani, J. Org. Chem., 2018, 83, 4307–4322.
W. G. Levine, Drug Metab. Rev., 1991, 23, 253–309.
A. A. Beharry, L. Wong, V. Tropepe and G. A. Woolley, Angew. Chem., Int. Ed., 2011, 50, 1325–1327.
L. Stricker, M. Böckmann, T. M. Kirse, N. L. Doltsinis and B. J. Ravoo, Chem. - Eur.J., 2018, 24, 8639.
C. Renner and L. Moroder, ChemBioChem, 2006, 7, 868–878.
S. Zbaida, Drug Metab. Rev., 1995, 27, 497–516.
C. Boulègue, M. Löweneck, C. Renner and L. Moroder, ChemBioChem, 2007, 8, 591–594.
W. A. Velema, W. Szymanski and B. L. Feringa, J. Am. Chem. Soc., 2014, 136, 2178–2191.
B. A. Thaher, M. Arnsmann, F. Totzke, J. E. Ehlert, M. H. G. Kubbutat, C. Schächtele, M. O. Zimmermann, P. Koch, F. M. Boeckler and S. A. Laufer, J. Med. Chem., 2012, 55, 961–965.
A. Freitag and S. A. Laufer, Nachr. Chem., 2015, 63, 420–425.
Acknowledgements
The authors from Kiel university acknowledge financial support by the Deutsche Forschungsgesellschaft (DFG) within the Sonderforschungsbereich 677, “Function by Switching”. Chiara Ianes is financially supported by a grant of the medical faculty of Ulm University (“Bausteinprogramm”)awarded to Joachim Bischof. Work in the lab of Uwe Knippschild was supported by the DFG (KN356/6-1, and SFB 1149, project B04). Daniel Rauh is thankful for support from the German Federal Ministry for Education and Research (NGFNPlus and e:Med) (Grant No. BMBF 01GS08104, 01ZX1303C), the Deutsche Forschungsgemeinschaft (DFG) and the German federal state North Rhine Westphalia (NRW) and the European Union (European Regional Development Fund: Investing In Your Future) (EFRE-800400). The crystallographic experiments leading to these results have received funding from the European Community'sSeventh Framework Programme (FP7/2007-2013) under grant agreement No. 283570 (BioStruct-X). CKLS crystals were growninthe Cologne Crystallization facility (http://C2f.uni-koeIn.de/). We thank the staff at the Swiss Light Source, Paul Scherrer Institute, Villigen, Switzerland for their support during data collection. We gratefully acknowledge the help of Dr Dieter Schollmeyer, University of Mainz, Institute for Organic Chemistry, Germany, for X-ray analysis of compound 13.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Schehr, M., Lanes, C., Weisner, J. et al. 2-Azo-, 2-diazocine-thiazols and 2-azo-imidazoles as photoswitchable kinase inhibitors: limitations and pitfalls of the photoswitchable inhibitor approach. Photochem Photobiol Sci 18, 1398–1407 (2019). https://doi.org/10.1039/c9pp00010k
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/c9pp00010k